We Underdose Antibiotics in Patients on CRRT

Area of Science:

• Pharmacology
• Nephrology
• Critical Care Medicine

Background:

• Optimizing antibiotic dosing in critically ill patients undergoing continuous renal replacement therapy (CRRT) is essential for effective infection treatment.
• Pharmacokinetic alterations in sepsis, including changes in volume of distribution and clearances, complicate antibiotic dosing.
• Current CRRT practices and outdated pharmacokinetic data lead to suboptimal antibiotic regimens and potential treatment failure.

Purpose of the Study:

• To evaluate the likelihood of achieving pharmacokinetic/pharmacodynamic (PK/PD) targets for antibiotics in patients on CRRT.
• To highlight the challenges in antibiotic dosing due to CRRT variability and lack of standardized protocols.
• To provide evidence-based recommendations for antibiotic dosing strategies in this complex patient population, using cefepime as a case study.

Main Methods:

• Review of existing literature on antibiotic pharmacokinetics during CRRT.
• Analysis of PK/PD target attainment for cefepime using current dosing recommendations.
• Comparison of older CRRT methodologies with contemporary practices to assess the relevance of historical dosing data.

Main Results:

• Many currently recommended antibiotic dosing regimens fail to achieve desired PK/PD targets in patients on CRRT.
• Variability in CRRT methods significantly impacts antibiotic removal, making standardized dosing difficult.
• Older studies using outdated CRRT techniques provide inaccurate dosing recommendations for modern clinical practice.

Conclusions:

• Clinicians should adopt aggressive antibiotic dosing strategies, including larger loading doses and higher maintenance doses.
• Achieving therapeutic targets requires higher antibiotic concentrations than often prescribed.
• Further research is needed to develop updated, reliable dosing guidelines for antibiotics in CRRT patients.